Cargando…
Exploiting of Green Synthesized Metal Oxide Nanoparticles for Spectrophotometric Determination of Levofloxacin, Cephalexin, and Cefotaxime Sodium in Commercial Products
In this study, two metal oxide nanoparticles NiO and MnO(2) were synthesized from green sources Mentha spicata (M. spicata) extract and Malus domestica (M. domestica) peel extract, respectively. The optical and physical properties of the synthesized nanoparticles were characterized using spectroscop...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145000/ https://www.ncbi.nlm.nih.gov/pubmed/33923143 http://dx.doi.org/10.3390/nano11051099 |
_version_ | 1783697078199779328 |
---|---|
author | Alarfaj, Nawal Ahmed Al-Onazi, Wedad Altuhami Al-Mohaimeed, Amal Mohammed El-Tohamy, Maha Farouk Alabdulmonem, Hadeel Abdulaziz |
author_facet | Alarfaj, Nawal Ahmed Al-Onazi, Wedad Altuhami Al-Mohaimeed, Amal Mohammed El-Tohamy, Maha Farouk Alabdulmonem, Hadeel Abdulaziz |
author_sort | Alarfaj, Nawal Ahmed |
collection | PubMed |
description | In this study, two metal oxide nanoparticles NiO and MnO(2) were synthesized from green sources Mentha spicata (M. spicata) extract and Malus domestica (M. domestica) peel extract, respectively. The optical and physical properties of the synthesized nanoparticles were characterized using spectroscopic and microscopic techniques. Simple, precise, and new spectrophotometric probes were suggested for the determination of three cephalosporin antibiotics, including levofloxacin (LVX), cephalexin (CPX), and cefotaxime sodium (CTX) in their pure form and commercial products. The spectrophotometric detection of the selected drugs is based on the catalytic enhancement of NiO and MnO(2) nanoparticles (NPs) due to their unique optical properties. Linear relationships with main correlation coefficients 0.999 were obtained at 0.1–20, 1.0–80, and 0.001–100 µg mL(−1) for the three drugs in the presence of NiONPs, whereas 0.01–60, 0.1–160, and 0.01–80 µg mL(−1) were obtained in the presence of MnO(2)NPs at absorption wavelengths 290, 262, and 235 nm for LVX, CPX and CTX, respectively. The analytical methods were validated and successfully used for determination of the instigated drugs in their bulk and commercial dosage forms. |
format | Online Article Text |
id | pubmed-8145000 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81450002021-05-26 Exploiting of Green Synthesized Metal Oxide Nanoparticles for Spectrophotometric Determination of Levofloxacin, Cephalexin, and Cefotaxime Sodium in Commercial Products Alarfaj, Nawal Ahmed Al-Onazi, Wedad Altuhami Al-Mohaimeed, Amal Mohammed El-Tohamy, Maha Farouk Alabdulmonem, Hadeel Abdulaziz Nanomaterials (Basel) Article In this study, two metal oxide nanoparticles NiO and MnO(2) were synthesized from green sources Mentha spicata (M. spicata) extract and Malus domestica (M. domestica) peel extract, respectively. The optical and physical properties of the synthesized nanoparticles were characterized using spectroscopic and microscopic techniques. Simple, precise, and new spectrophotometric probes were suggested for the determination of three cephalosporin antibiotics, including levofloxacin (LVX), cephalexin (CPX), and cefotaxime sodium (CTX) in their pure form and commercial products. The spectrophotometric detection of the selected drugs is based on the catalytic enhancement of NiO and MnO(2) nanoparticles (NPs) due to their unique optical properties. Linear relationships with main correlation coefficients 0.999 were obtained at 0.1–20, 1.0–80, and 0.001–100 µg mL(−1) for the three drugs in the presence of NiONPs, whereas 0.01–60, 0.1–160, and 0.01–80 µg mL(−1) were obtained in the presence of MnO(2)NPs at absorption wavelengths 290, 262, and 235 nm for LVX, CPX and CTX, respectively. The analytical methods were validated and successfully used for determination of the instigated drugs in their bulk and commercial dosage forms. MDPI 2021-04-24 /pmc/articles/PMC8145000/ /pubmed/33923143 http://dx.doi.org/10.3390/nano11051099 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Alarfaj, Nawal Ahmed Al-Onazi, Wedad Altuhami Al-Mohaimeed, Amal Mohammed El-Tohamy, Maha Farouk Alabdulmonem, Hadeel Abdulaziz Exploiting of Green Synthesized Metal Oxide Nanoparticles for Spectrophotometric Determination of Levofloxacin, Cephalexin, and Cefotaxime Sodium in Commercial Products |
title | Exploiting of Green Synthesized Metal Oxide Nanoparticles for Spectrophotometric Determination of Levofloxacin, Cephalexin, and Cefotaxime Sodium in Commercial Products |
title_full | Exploiting of Green Synthesized Metal Oxide Nanoparticles for Spectrophotometric Determination of Levofloxacin, Cephalexin, and Cefotaxime Sodium in Commercial Products |
title_fullStr | Exploiting of Green Synthesized Metal Oxide Nanoparticles for Spectrophotometric Determination of Levofloxacin, Cephalexin, and Cefotaxime Sodium in Commercial Products |
title_full_unstemmed | Exploiting of Green Synthesized Metal Oxide Nanoparticles for Spectrophotometric Determination of Levofloxacin, Cephalexin, and Cefotaxime Sodium in Commercial Products |
title_short | Exploiting of Green Synthesized Metal Oxide Nanoparticles for Spectrophotometric Determination of Levofloxacin, Cephalexin, and Cefotaxime Sodium in Commercial Products |
title_sort | exploiting of green synthesized metal oxide nanoparticles for spectrophotometric determination of levofloxacin, cephalexin, and cefotaxime sodium in commercial products |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145000/ https://www.ncbi.nlm.nih.gov/pubmed/33923143 http://dx.doi.org/10.3390/nano11051099 |
work_keys_str_mv | AT alarfajnawalahmed exploitingofgreensynthesizedmetaloxidenanoparticlesforspectrophotometricdeterminationoflevofloxacincephalexinandcefotaximesodiumincommercialproducts AT alonaziwedadaltuhami exploitingofgreensynthesizedmetaloxidenanoparticlesforspectrophotometricdeterminationoflevofloxacincephalexinandcefotaximesodiumincommercialproducts AT almohaimeedamalmohammed exploitingofgreensynthesizedmetaloxidenanoparticlesforspectrophotometricdeterminationoflevofloxacincephalexinandcefotaximesodiumincommercialproducts AT eltohamymahafarouk exploitingofgreensynthesizedmetaloxidenanoparticlesforspectrophotometricdeterminationoflevofloxacincephalexinandcefotaximesodiumincommercialproducts AT alabdulmonemhadeelabdulaziz exploitingofgreensynthesizedmetaloxidenanoparticlesforspectrophotometricdeterminationoflevofloxacincephalexinandcefotaximesodiumincommercialproducts |